Please assess the completion status of the following clinical trial:

Trial Title: A Comparative Study of JNS013 in Participants With Post-Tooth-Extraction Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Participants planned to receive a tooth extraction of one mandibular impacted wisdom tooth~* Participants who require bone removal and separation of the crown at tooth extraction~* Participants whose intensity of pain associated with tooth extraction within 2 hours after tooth extraction is greater than or equal to 50.0 millimeter on the visual analog scale (VAS)~* Participants who did not undergo general anesthesia or sedation at tooth extraction~* Participants without an abnormality (including laboratory test values) corresponding to Grade 3 in the Criteria for severity classification of adverse drug reactions during the pretreatment observation period~Exclusion Criteria:~* Participants with conditions for which tramadol is contraindicated~* Participants with conditions for which acetaminophen is contraindicated~* Participants with history of convulsions or the possibility of convulsive seizures~* Pregnant participants or those who may be pregnant, lactating mothers, and those who wish pregnancy during the study period~* Participants with concurrent, previous, or possible alcohol dependence, drug dependence or narcotic addiction

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 74 Years
- Healthy Volunteers: f

Study Arms:
- Tramadol plus Acetaminophen and Placebo (Type: EXPERIMENTAL): Tramadol hydrochloride and acetaminophen combination tablet will be administered as single oral dosing of two tablets at a dose of 75 and 650 milligram respectively, along with two oral capsules of matching placebo, within 30 minutes after the intensity of pain associated with tooth extraction showed greater than or equal to (\>=) 50.0 millimeter (mm) on the Visual Analog Scale (VAS), score ranging from 0 mm (no pain) to 100 mm (worst possible pain).
- Tramadol and Placebo (Type: EXPERIMENTAL): Tramadol hydrochloride will be administered as single oral dosing of two capsules once at a dose of 75 milligram, along with two oral tablets of matching placebo, within 30 minutes after the intensity of pain associated with tooth extraction showed \>= 50.0 mm on the VAS, score ranging from 0 mm (no pain) to 100 mm (worst possible pain).
- Acetaminophen and Placebo (Type: EXPERIMENTAL): Acetaminophen will be administered as single oral dosing of two capsules once at a dose of 650 milligram, along with two oral tablets of matching placebo, within 30 minutes after the intensity of pain associated with tooth extraction showed \>= 50.0 mm on the VAS, score ranging from 0 mm (no pain) to 100 mm (worst possible pain).

Based on this trial design, predict the completion outcome and termination type (if applicable).